The production of SCFAs following mucin degradation is likely to act as an energy source for IECs to aid further mucin secretion
Its recognised international non-proprietary name is emideltide
Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) BPC157 Overview and How It Works BPC157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice
Dao-Chi powder ameliorates pancreatitis-induced intestinal and cardiac injuries via regulating the Nrf2-HO-1-HMGB1 signaling pathway in rats
While not an active malignancy, the peptides mechanisms for promoting cell growth and blood vessel formation are a theoretical concern
Elevated homocysteine levels (which rise when vitamin B12, folic acid, or vitamin B6 are low) have also been associated in observational studies with higher rates of Alzheimers disease and dementia
